Adoptive T Cell Therapy Targeting CD1 and MR1

Overview of attention for article published in Frontiers in immunology, May 2015

Altmetric Badge

Mentioned by

twitter: 3 X users

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 34,603 followers.

#Adoptive #T-Cell #Therapy #Targeting #CD1 and #MR1 http://t.co/PyAcPPKSih (followed by Marc #Lacroix, #Wallonie)

Reply Repost Favourite

#Adoptive #T-Cell #Therapy #Targeting #CD1 and #MR1 http://t.co/PyAcPPKSih (followed by Marc #Lacroix, #Wallonie)

Reply Repost Favourite

Adoptive T cell therapy targeting CD1 and MR1: Tingxi Guo, Kenji Chamoto, Naoto Hirano http://t.co/eSiKlaX0dn #Immunology

Reply Repost Favourite

Adoptive T cell therapy targeting CD1 and MR1: Tingxi Guo, Kenji Chamoto, Naoto Hirano http://t.co/eSiKlaX0dn #Immunology

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.